Tourmaline Bio (TRML) Institutional Ownership $24.00 +0.50 (+2.13%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)CurrentInstitutional OwnershipPercentage91.89%Number ofInstitutional Buyers(last 12 months)43TotalInstitutional Inflows(last 12 months)$212.01MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.93M Get TRML Insider Trade Alerts Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRML Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Tourmaline Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC31,833$819K0.0%+283.7%0.124% 11/16/2024 Geode Capital Management LLC482,078$12.40M0.0%+6.4%1.880% 11/15/2024 Barclays PLC31,833$819K0.0%+283.7%0.124% 11/15/2024 Jane Street Group LLC21,705$558K0.0%-211.3%0.085% 11/15/2024 Wellington Management Group LLP65,741$1.69M0.0%+72.8%0.256% 11/15/2024 State Street Corp411,980$10.59M0.0%+25.6%1.607% Get the Latest News and Ratings for TRML and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Point72 Asset Management L.P.338,437$8.70M0.0%N/A1.320% 11/14/2024 Acuta Capital Partners LLC332,095$8.54M6.9%+23.2%1.295% 11/14/2024 MetLife Investment Management LLC13,886$357K0.0%N/A0.054% 11/13/2024 BNP Paribas Financial Markets13,348$343K0.0%-7.8%0.052% 11/13/2024 FMR LLC15,063$387K0.0%-93.6%0.059% 11/13/2024 The Manufacturers Life Insurance Company 8,804$226K0.0%N/A0.034% 11/12/2024 Charles Schwab Investment Management Inc.63,571$1.63M0.0%+3.5%0.248% 11/8/2024 Jennison Associates LLC1,151,973$29.62M0.0%+2.2%4.493% 11/7/2024 Quest Partners LLC9,381$241K0.0%+145.4%0.037% 10/30/2024 AlphaCentric Advisors LLC5,500$141K0.1%-92.7%0.021% 10/25/2024 China Universal Asset Management Co. Ltd.4,932$127K0.0%+63.7%0.019% 9/16/2024 Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/16/2024 Algert Global LLC39,866$513K0.0%+122.7%0.155% 8/15/2024 Blue Owl Capital Holdings LP1,715,401$22.06M6.2%+18.5%6.689% 8/14/2024 Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/14/2024 Marshall Wace LLP170,447$2.19M0.0%+22.3%0.665% 8/14/2024 HighVista Strategies LLC83,397$1.07M0.4%+57.2%0.325% 8/9/2024 Renaissance Technologies LLC100,076$1.29M0.0%+184.9%0.390% 8/6/2024 Quest Partners LLC3,822$49K0.0%+134.0%0.015% 8/1/2024 Rhumbline Advisers33,239$427K0.0%+28,554.3%0.130% 7/26/2024 Bank of New York Mellon Corp70,697$909K0.0%N/A0.276% 7/26/2024 AlphaCentric Advisors LLC75,000$964K0.7%+22.7%0.292% 7/12/2024 SG Americas Securities LLC33,666$433K0.0%N/A0.131% 5/17/2024 Artal Group S.A.314,496$7.20M0.2%+244.0%1.226% 5/16/2024 California State Teachers Retirement System14,578$334K0.0%N/A0.057% 5/16/2024 Janus Henderson Group PLC11,593$266K0.0%N/A0.045% 5/15/2024 Darwin Global Management Ltd.465,000$10.65M1.4%N/A1.813% 5/15/2024 Avoro Capital Advisors LLC2,222,222$50.89M0.6%+155.9%8.664% 5/15/2024 Altitude Crest Partners Inc.47,400$1.09M0.5%N/A0.185% 5/15/2024 Affinity Asset Advisors LLC50,000$1.15M0.1%-26.6%0.195% 5/14/2024 Qiming U.S. Ventures Management LLC741,691$16.99M18.9%+15.6%2.892% 5/14/2024 Nan Fung Group Holdings Ltd20,987$481K0.4%N/A0.082% 5/14/2024 StemPoint Capital LP274,219$6.28M1.7%N/A1.069% 5/10/2024 Vanguard Group Inc.914,519$20.94M0.0%+19.7%3.566% Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin.5/7/2024 Swiss National Bank32,000$733K0.0%N/A0.125% 5/2/2024 Jennison Associates LLC1,115,251$25.54M0.0%N/A4.348% 5/1/2024 BNP Paribas Financial Markets1,346$31K0.0%N/A0.005% 4/29/2024 China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019% 4/19/2024 Denali Advisors LLC5,600$128K0.0%N/A0.022% 2/15/2024 Great Point Partners LLC672,885$17.62M3.0%N/A3.308% 2/14/2024 Braidwell LP906,820$23.74M0.9%N/A4.458% 2/14/2024 Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269% 2/14/2024 RTW Investments LP398,850$10.44M0.2%N/A1.961% 2/13/2024 Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335% 2/7/2024 Jump Financial LLC14,500$380K0.0%N/A0.071% 2/7/2024 Vivo Capital LLC591,882$15.50M1.3%N/A2.910% 1/30/2024 BML Capital Management LLC245,500$6.43M4.9%N/A1.207% (Data available from 1/1/2016 forward) TRML Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRML shares? During the previous two years, 44 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Avoro Capital Advisors LLC ($50.89M), Jennison Associates LLC ($29.62M), Braidwell LP ($23.74M), Blue Owl Capital Holdings LP ($22.06M), Vanguard Group Inc. ($20.94M), Great Point Partners LLC ($17.62M), and Qiming U.S. Ventures Management LLC ($16.99M).Learn more on TRML's institutional investors. What percentage of Tourmaline Bio stock is owned by institutional investors? 91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings. Which institutional investors have been buying Tourmaline Bio stock? Of the 43 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($2.22M), Jennison Associates LLC ($1.14M), Braidwell LP ($906.82K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), Darwin Global Management Ltd. ($465K), and RTW Investments LP ($398.85K). How much institutional buying is happening at Tourmaline Bio? Institutional investors have bought a total of 8,917,173 shares in the last 24 months. This purchase volume represents approximately $212.01M in transactions. Which Tourmaline Bio major shareholders have been selling company stock? The following institutional investors have sold Tourmaline Bio stock in the last 24 months: FMR LLC ($221.67K), AlphaCentric Advisors LLC ($69.50K), Affinity Asset Advisors LLC ($18.08K), and BNP Paribas Financial Markets ($1.13K). How much institutional selling is happening at Tourmaline Bio? Institutional investors have sold a total of 310,378 shares in the last 24 months. This volume of shares sold represents approximately $7.93M in transactions. Related Companies Longboard Pharmaceuticals Major Shareholders Arrowhead Pharmaceuticals Major Shareholders Protagonist Therapeutics Major Shareholders IDEAYA Biosciences Major Shareholders Keros Therapeutics Major Shareholders CG Oncology Major Shareholders Wave Life Sciences Major Shareholders Akero Therapeutics Major Shareholders Amphastar Pharmaceuticals Major Shareholders Mirum Pharmaceuticals Major Shareholders This page (NASDAQ:TRML) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRML Stock Alerts